Drug evaluation: Bay-59-8862. [IDrugs. 2004] - PubMed

Related citations

The discovery of BMS-275183: an orally efficacious novel taxane. [Bioorg Med Chem. 2003]
The discovery of BMS-275183: an orally efficacious novel taxane.
Mastalerz H, Cook D, Fairchild CR, Hansel S, Johnson W, Kadow JF, Long BH, Rose WC, Tarrant J, Wu MJ, et al. Bioorg Med Chem. 2003 Oct 1; 11(20):4315-23.
Synthesis and biological evaluation of methoxylated analogs of the newer generation taxoids IDN5109 and IDN5390. [Bioorg Med Chem Lett. 2005]
Synthesis and biological evaluation of methoxylated analogs of the newer generation taxoids IDN5109 and IDN5390.
Barboni L, Ballini R, Giarlo G, Appendino G, Fontana G, Bombardelli E. Bioorg Med Chem Lett. 2005 Dec 1; 15(23):5182-6. Epub 2005 Sep 23.
Review Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative. [Curr Opin Investig Drugs. 2006]
Review Drug evaluation: tesetaxel--an oral semisynthetic taxane derivative.
Roche M, Kyriakou H, Seiden M. Curr Opin Investig Drugs. 2006 Dec; 7(12):1092-9.
IDN5109, a taxane with oral bioavailability and potent antitumor activity. [Cancer Res. 2000]
IDN5109, a taxane with oral bioavailability and potent antitumor activity.
Nicoletti MI, Colombo T, Rossi C, Monardo C, Stura S, Zucchetti M, Riva A, Morazzoni P, Donati MB, Bombardelli E, et al. Cancer Res. 2000 Feb 15; 60(4):842-6.
Review Critical appraisal of cabazitaxel in the management of advanced prostate cancer. [Clin Interv Aging. 2010]
Review Critical appraisal of cabazitaxel in the management of advanced prostate cancer.
Pal SK, Twardowski P, Sartor O. Clin Interv Aging. 2010 Dec 3; 5:395-402. Epub 2010 Dec 3.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.

Recent activity

Clear Turn Off Turn On

Drug evaluation: Bay-59-8862.
Drug evaluation: Bay-59-8862.
IDrugs. 2004 Jun ;7(6):575-81.

PubMed
HIV infection changes glomerular podocyte cytoskeletal composition and results i...
HIV infection changes glomerular podocyte cytoskeletal composition and results in distinct cellular mechanical properties.
Am J Physiol Renal Physiol. 2007 Feb ;292(2):F701-10. Epub 2006 Oct 17 .

PubMed
Gene mutations in human haemoglobin: the chemical difference between normal and ...
Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin.
Nature. 1957 Aug 17 ;180(4581):326-8.

PubMed
Identifying patients, on the first day of life, at high-risk of developing paren...
Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease.
J Perinatol. 2007 May ;27(5):284-90. Epub 2007 Mar 8 .

PubMed
SCF(Pof1)-ubiquitin and its target Zip1 transcription factor mediate cadmium res...
SCF(Pof1)-ubiquitin and its target Zip1 transcription factor mediate cadmium response in fission yeast.
EMBO J. 2005 Feb 9 ;24(3):599-610. Epub 2005 Jan 20 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Drug evaluation: Bay-59-8862.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information